Chemoinformaics analysis of 2,2,7-TRIMETHYL-3-OCTYNE
| Molecular Weight | 152.281 | nRot | 2 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 1 |
| Exact Molecular Weight | 152.156 | nRing | 0 |
| Solubility: LogS | -4.815 | nHRing | 0 |
| Solubility: LogP | 4.633 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 31.7059 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.531 |
| Synth | 2.849 |
| Natural Product Likeliness | 0.632 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.807 |
| Pgp-sub | 0 |
| HIA | 0.016 |
| CACO-2 | -4.357 |
| MDCK | 0.0000163 |
| BBB | 0.771 |
| PPB | 0.969217 |
| VDSS | 2.035 |
| FU | 0.00815767 |
| CYP1A2-inh | 0.855 |
| CYP1A2-sub | 0.857 |
| CYP2c19-inh | 0.951 |
| CYP2c19-sub | 0.931 |
| CYP2c9-inh | 0.884 |
| CYP2c9-sub | 0.966 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.389 |
| CYP3a4-inh | 0.311 |
| CYP3a4-sub | 0.223 |
| CL | 8.849 |
| T12 | 0.354 |
| hERG | 0.011 |
| Ames | 0.006 |
| ROA | 0.032 |
| SkinSen | 0.424 |
| Carcinogencity | 0.107 |
| EI | 0.985 |
| Respiratory | 0.093 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.824557 |